Results 51 to 60 of about 28,111,627 (303)
Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada [PDF]
Although information on efficacy and adverse drug reactions is lacking, ribavirin has been used empirically for the treatment of severe acute respiratory syndrome (SARS). We report common adverse events in 110 patients with suspected or probable SARS who
Dresser, L. +7 more
core +1 more source
Reduced frequency of migraine attacks following coronavirus disease 2019: a case report
Background Severe acute respiratory syndrome coronavirus 2 is a virus affecting different organs and causing a wide variety and severity of symptoms. Headache as well as loss of smell and taste are the most frequently reported neurological manifestations
Roland Houben
doaj +1 more source
Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia [PDF]
Coronavirus disease (COVID-19) in Colombia was first diagnosed in a traveler arriving from Italy on February 26, 2020. However, limited data are available on the origins and number of introductions of COVID-19 into the country. We sequenced the causative agent of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from 43 clinical ...
Katherine Laiton‐Donato +16 more
openaire +5 more sources
The SARS-coronavirus-host interactome [PDF]
Coronaviruses (CoVs) are important human and animal pathogens that induce fatal respiratory, gastrointestinal and neurological disease. The outbreak of the severe acute respiratory syndrome (SARS) in 2002/2003 has demonstrated human vulnerability to ...
Brunn, Albrecht von +27 more
core +1 more source
BACKGROUND: Health authorities worldwide, especially in the Asia Pacific region, are seeking effective public-health interventions in the continuing epidemic of severe acute respiratory syndrome (SARS).
Donnelly, CA +37 more
core +2 more sources
A Family Cluster of Severe Acute Respiratory Syndrome Coronavirus 2 Infections [PDF]
Abstract Background In December 2019, the outbreak of 2019 novel coronavirus disease (COVID-19) began in Wuhan, Hubei Province, China. The disease has rapidly spread from Wuhan to other provinces and other countries. Clinical and epidemiological knowledge is limited.
Xuesong Gao +9 more
openaire +3 more sources
Binding and entering: COVID finds a new home.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged as a virus with a pathogenicity closer to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and a transmissibility ...
Michelle N Vu, Vineet D Menachery
doaj +1 more source
Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019
Purpose of review In December 2019, a novel respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first described and named coronavirus disease 2019 (COVID-19). Although the knowledge base surrounding COVID-19 and SARS-CoV-2 has grown rapidly, significant gaps in our knowledge remain and
Timberlake, Dylan T. +2 more
openaire +2 more sources
Mathematical modeling of the spread of the coronavirus under strict social restrictions
We formulate a simple susceptible‐infectious‐recovery (SIR) model to describe the spread of the coronavirus under strict social restrictions. The transmission rate in this model is exponentially decreasing with time. We find a formula for basic reproduction function and estimate the maximum number of daily infected individuals.
Mo'tassem Al‐arydah +3 more
wiley +1 more source
Background Like other viral infections, severe acute respiratory syndrome coronavirus-2 infection could affect different human body systems, including host immune responses. Three years after its pandemic, we learn more about this novel coronavirus.
Ali Amanati +7 more
doaj +1 more source

